The company aims to hold and further develop intellectual property rights in the field of innovative low-molecular-weight medicines for the treatment of cancer and immune diseases, as well as in the field of new therapies to improve quality of life, extend life expectancy and eliminate significant unresolved medical problems in healthcare. The company may establish branches and subsidiaries in Switzerland and abroad. The company may provide financing and similar services to affiliated companies, i.e. direct or indirect subsidiaries, direct or indirect sister companies, or direct or indirect parent companies, whether by way of loans, advances, guarantees or other securities of any kind, whether against payment or not. The company may acquire, hold, manage, exploit and sell real estate and intellectual property rights in Switzerland and abroad. The company may carry out all activities and take all measures that appear suitable to promote the purpose of the company or are connected therewith.
Outbound Leads by COHAGA